Cargando…
Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM
OBJECTIVES: Distinguishing hypertrophic cardiomyopathy (HCM) from left ventricular hypertrophy (LVH) due to systematic training (athlete’s heart, AH) from morphologic assessment remains challenging. The purpose of this study was to examine the role of T2 mapping and deformation imaging obtained by c...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043946/ https://www.ncbi.nlm.nih.gov/pubmed/33063183 http://dx.doi.org/10.1007/s00330-020-07289-4 |
_version_ | 1783678400892764160 |
---|---|
author | Gastl, Mareike Lachmann, Vera Christidi, Aikaterini Janzarik, Nico Veulemans, Verena Haberkorn, Sebastian Holzbach, Leonie Jacoby, Christoph Schnackenburg, Bernhard Berrisch-Rahmel, Susanne Zeus, Tobias Kelm, Malte Bönner, Florian |
author_facet | Gastl, Mareike Lachmann, Vera Christidi, Aikaterini Janzarik, Nico Veulemans, Verena Haberkorn, Sebastian Holzbach, Leonie Jacoby, Christoph Schnackenburg, Bernhard Berrisch-Rahmel, Susanne Zeus, Tobias Kelm, Malte Bönner, Florian |
author_sort | Gastl, Mareike |
collection | PubMed |
description | OBJECTIVES: Distinguishing hypertrophic cardiomyopathy (HCM) from left ventricular hypertrophy (LVH) due to systematic training (athlete’s heart, AH) from morphologic assessment remains challenging. The purpose of this study was to examine the role of T2 mapping and deformation imaging obtained by cardiovascular magnetic resonance (CMR) to discriminate AH from HCM with (HOCM) or without outflow tract obstruction (HNCM). METHODS: Thirty-three patients with HOCM, 9 with HNCM, 13 strength-trained athletes as well as individual age- and gender-matched controls received CMR. For T2 mapping, GRASE-derived multi-echo images were obtained and analyzed using dedicated software. Besides T2 mapping analyses, left ventricular (LV) dimensional and functional parameters were obtained including LV mass per body surface area (LVMi), interventricular septum thickness (IVS), and global longitudinal strain (GLS). RESULTS: While LVMi was not significantly different, IVS was thickened in HOCM patients compared to athlete’s. Absolute values of GLS were significantly increased in patients with HOCM/HNCM compared to AH. Median T2 values were elevated compared to controls except in athlete’s heart. ROC analysis revealed T2 values (AUC 0.78) and GLS (AUC 0.91) as good parameters to discriminate AH from overall HNCM/HOCM. CONCLUSION: Discrimination of pathologic from non-pathologic LVH has implications for risk assessment of competitive sports in athletes. Multiparametric CMR with parametric T2 mapping and deformation imaging may add information to distinguish AH from LVH due to HCM. KEY POINTS: • Structural analyses using T2 mapping cardiovascular magnetic resonance imaging (CMR) may help to further distinguish myocardial diseases. • To differentiate pathologic from non-pathologic left ventricular hypertrophy, CMR including T2 mapping was obtained in patients with hypertrophic obstructive/non-obstructive cardiomyopathy (HOCM/HNCM) as well as in strength-trained athletes. • Elevated median T2 values in HOCM/HNCM compared with athlete’s may add information to distinguish athlete’s heart from pathologic left ventricular hypertrophy. |
format | Online Article Text |
id | pubmed-8043946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-80439462021-04-27 Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM Gastl, Mareike Lachmann, Vera Christidi, Aikaterini Janzarik, Nico Veulemans, Verena Haberkorn, Sebastian Holzbach, Leonie Jacoby, Christoph Schnackenburg, Bernhard Berrisch-Rahmel, Susanne Zeus, Tobias Kelm, Malte Bönner, Florian Eur Radiol Cardiac OBJECTIVES: Distinguishing hypertrophic cardiomyopathy (HCM) from left ventricular hypertrophy (LVH) due to systematic training (athlete’s heart, AH) from morphologic assessment remains challenging. The purpose of this study was to examine the role of T2 mapping and deformation imaging obtained by cardiovascular magnetic resonance (CMR) to discriminate AH from HCM with (HOCM) or without outflow tract obstruction (HNCM). METHODS: Thirty-three patients with HOCM, 9 with HNCM, 13 strength-trained athletes as well as individual age- and gender-matched controls received CMR. For T2 mapping, GRASE-derived multi-echo images were obtained and analyzed using dedicated software. Besides T2 mapping analyses, left ventricular (LV) dimensional and functional parameters were obtained including LV mass per body surface area (LVMi), interventricular septum thickness (IVS), and global longitudinal strain (GLS). RESULTS: While LVMi was not significantly different, IVS was thickened in HOCM patients compared to athlete’s. Absolute values of GLS were significantly increased in patients with HOCM/HNCM compared to AH. Median T2 values were elevated compared to controls except in athlete’s heart. ROC analysis revealed T2 values (AUC 0.78) and GLS (AUC 0.91) as good parameters to discriminate AH from overall HNCM/HOCM. CONCLUSION: Discrimination of pathologic from non-pathologic LVH has implications for risk assessment of competitive sports in athletes. Multiparametric CMR with parametric T2 mapping and deformation imaging may add information to distinguish AH from LVH due to HCM. KEY POINTS: • Structural analyses using T2 mapping cardiovascular magnetic resonance imaging (CMR) may help to further distinguish myocardial diseases. • To differentiate pathologic from non-pathologic left ventricular hypertrophy, CMR including T2 mapping was obtained in patients with hypertrophic obstructive/non-obstructive cardiomyopathy (HOCM/HNCM) as well as in strength-trained athletes. • Elevated median T2 values in HOCM/HNCM compared with athlete’s may add information to distinguish athlete’s heart from pathologic left ventricular hypertrophy. Springer Berlin Heidelberg 2020-10-15 2021 /pmc/articles/PMC8043946/ /pubmed/33063183 http://dx.doi.org/10.1007/s00330-020-07289-4 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Cardiac Gastl, Mareike Lachmann, Vera Christidi, Aikaterini Janzarik, Nico Veulemans, Verena Haberkorn, Sebastian Holzbach, Leonie Jacoby, Christoph Schnackenburg, Bernhard Berrisch-Rahmel, Susanne Zeus, Tobias Kelm, Malte Bönner, Florian Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM |
title | Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM |
title_full | Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM |
title_fullStr | Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM |
title_full_unstemmed | Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM |
title_short | Cardiac magnetic resonance T2 mapping and feature tracking in athlete’s heart and HCM |
title_sort | cardiac magnetic resonance t2 mapping and feature tracking in athlete’s heart and hcm |
topic | Cardiac |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043946/ https://www.ncbi.nlm.nih.gov/pubmed/33063183 http://dx.doi.org/10.1007/s00330-020-07289-4 |
work_keys_str_mv | AT gastlmareike cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm AT lachmannvera cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm AT christidiaikaterini cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm AT janzariknico cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm AT veulemansverena cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm AT haberkornsebastian cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm AT holzbachleonie cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm AT jacobychristoph cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm AT schnackenburgbernhard cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm AT berrischrahmelsusanne cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm AT zeustobias cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm AT kelmmalte cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm AT bonnerflorian cardiacmagneticresonancet2mappingandfeaturetrackinginathletesheartandhcm |